Debate: Treatment of patients with recurrent ovarian cancer should be treated with antiangiogenic agents in combination with chemotherapy Report uri icon

Overview

MeSH Major

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Immunotherapy, Adoptive
  • Ovarian Neoplasms

publication date

  • November 11, 2009

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.3816/COC.2009.n.002

Additional Document Info

start page

  • 12

end page

  • 18

volume

  • 2

number

  • 1